143 related articles for article (PubMed ID: 2842508)
1. Hotspot sites for acridine-induced frameshift mutations in bacteriophage T4 correspond to sites of action of the T4 type II topoisomerase.
Ripley LS; Dubins JS; deBoer JG; DeMarini DM; Bogerd AM; Kreuzer KN
J Mol Biol; 1988 Apr; 200(4):665-80. PubMed ID: 2842508
[TBL] [Abstract][Full Text] [Related]
2. The specificity of topoisomerase-mediated DNA cleavage defines acridine-induced frameshift specificity within a hotspot in bacteriophage T4.
Masurekar M; Kreuzer KN; Ripley LS
Genetics; 1991 Mar; 127(3):453-62. PubMed ID: 1849858
[TBL] [Abstract][Full Text] [Related]
3. The specificity of topoisomerase-mediated DNA cleavage defines acridine-induced frameshift specificity within a hotspot in bacteriophage T4.
Masurekar M; Krueuzer KN; Ripley LS
Genetics; 1991 May; 128(1):193. PubMed ID: 1648002
[No Abstract] [Full Text] [Related]
4. Deletion and duplication sequences induced in CHO cells by teniposide (VM-26), a topoisomerase II targeting drug, can be explained by the processing of DNA nicks produced by the drug-topoisomerase interaction.
Ripley LS
Mutat Res; 1994 Apr; 312(2):67-78. PubMed ID: 7510833
[TBL] [Abstract][Full Text] [Related]
5. DNA nick processing by exonuclease and polymerase activities of bacteriophage T4 DNA polymerase accounts for acridine-induced mutation specificities in T4.
Kaiser VL; Ripley LS
Proc Natl Acad Sci U S A; 1995 Mar; 92(6):2234-8. PubMed ID: 7892253
[TBL] [Abstract][Full Text] [Related]
6. Frameshift mutations produced by proflavin in bacteriophage T4: specificity within a hotspot.
Ripley LS; Clark A
Proc Natl Acad Sci U S A; 1986 Sep; 83(18):6954-8. PubMed ID: 3462738
[TBL] [Abstract][Full Text] [Related]
7. Site-specific recognition of bacteriophage T4 DNA by T4 type II DNA topoisomerase and Escherichia coli DNA gyrase.
Kreuzer KN; Alberts BM
J Biol Chem; 1984 Apr; 259(8):5339-46. PubMed ID: 6325431
[TBL] [Abstract][Full Text] [Related]
8. Mutational alteration of the breakage/resealing subunit of bacteriophage T4 DNA topoisomerase confers resistance to antitumor agent m-AMSA.
Huff AC; Ward RE; Kreuzer KN
Mol Gen Genet; 1990 Mar; 221(1):27-32. PubMed ID: 2157956
[TBL] [Abstract][Full Text] [Related]
9. Bacteriophage T4 DNA topoisomerase is the target of antitumor agent 4'-(9-acridinylamino)methanesulfon-m-anisidide (m-AMSA) in T4-infected Escherichia coli.
Huff AC; Leatherwood JK; Kreuzer KN
Proc Natl Acad Sci U S A; 1989 Feb; 86(4):1307-11. PubMed ID: 2537494
[TBL] [Abstract][Full Text] [Related]
10. A proflavin-induced frameshift hotspot in the thymidylate synthase gene of bacteriophage T4.
Brown MD; Ripley LS; Hall DH
Mutat Res; 1993 Apr; 286(2):189-97. PubMed ID: 7681530
[TBL] [Abstract][Full Text] [Related]
11. Common sites for recombination and cleavage mediated by bacteriophage T4 DNA topoisomerase in vitro.
Chiba M; Shimizu H; Fujimoto A; Nashimoto H; Ikeda H
J Biol Chem; 1989 Aug; 264(22):12785-90. PubMed ID: 2546934
[TBL] [Abstract][Full Text] [Related]
12. Bacteriophage T4 DNA topoisomerase mediates illegitimate recombination in vitro.
Ikeda H
Proc Natl Acad Sci U S A; 1986 Feb; 83(4):922-6. PubMed ID: 3006033
[TBL] [Abstract][Full Text] [Related]
13. A major role for bacteriophage T4 DNA polymerase in frameshift mutagenesis.
Ripley LS; Shoemaker NB
Genetics; 1983 Mar; 103(3):353-66. PubMed ID: 6840538
[TBL] [Abstract][Full Text] [Related]
14. Enhanced amsacrine-induced mutagenesis in plateau-phase Chinese hamster ovary cells, with targeting of +1 frameshifts to free 3' ends of topoisomerase II cleavable complexes.
Patteson K; Wang P; Povirk LF
Cancer Res; 1999 Aug; 59(15):3682-8. PubMed ID: 10446982
[TBL] [Abstract][Full Text] [Related]
15. Recognition of single-stranded DNA by the bacteriophage T4-induced type II topoisomerase.
Kreuzer KN
J Biol Chem; 1984 Apr; 259(8):5347-54. PubMed ID: 6325432
[TBL] [Abstract][Full Text] [Related]
16. Stimulation of site-specific topoisomerase II-mediated DNA cleavage by an N-methylpyrrolecarboxamide-anilinoacridine conjugate: relation to DNA binding.
Fossé P; René B; Saucier JM; Hénichart JP; Waring MJ; Colson P; Houssier C; Bailly C
Biochemistry; 1994 Aug; 33(33):9865-74. PubMed ID: 8060993
[TBL] [Abstract][Full Text] [Related]
17. Mutagenicity of topoisomerase-active agents in bacteriophage T4.
DeMarini DM; Lawrence BK
Teratog Carcinog Mutagen; 1988; 8(5):293-301. PubMed ID: 2905838
[TBL] [Abstract][Full Text] [Related]
18. Spectrum of spontaneous frameshift mutations. Sequences of bacteriophage T4 rII gene frameshifts.
Ripley LS; Clark A; deBoer JG
J Mol Biol; 1986 Oct; 191(4):601-13. PubMed ID: 3806675
[TBL] [Abstract][Full Text] [Related]
19. Linker length in podophyllotoxin-acridine conjugates determines potency in vivo and in vitro as well as specificity against MDR cell lines.
Rothenborg-Jensen L; Hansen HF; Wessel I; Nitiss JL; Schmidt G; Jensen PB; Sehested M; Jensen LH
Anticancer Drug Des; 2001 Dec; 16(6):305-15. PubMed ID: 12375883
[TBL] [Abstract][Full Text] [Related]
20. The spectrum of acridine resistant mutants of bacteriophage T4 reveals cryptic effects of the tsL141 DNA polymerase allele on spontaneous mutagenesis.
Wang FJ; Ripley LS
Genetics; 1998 Apr; 148(4):1655-65. PubMed ID: 9560385
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
